![Mark Citron](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Citron
Plus aucun poste en cours
Historique de carrière de Mark Citron
Anciens postes connus de Mark Citron
Sociétés | Poste | Début | Fin |
---|---|---|---|
BioMimetic Therapeutics, Inc.
![]() BioMimetic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioMimetic Therapeutics, Inc. developed and sells protein therapeutics for tissue and organ regeneration. The company was founded by Samuel E. Lynch and David M. Renzi on April 14, 1999 and was headquartered in Franklin, TN. | Conseiller Juridique Général | 01/01/2002 | 29/05/2007 |
TYRX, Inc.
![]() TYRX, Inc. Electronic Equipment/InstrumentsElectronic Technology TYRX, Inc. designs and manufactures medical-pharmaceutical combination devices. The firm commercializes implantable combination drug and device products focused on infection control including the AIGISRx Antibacterial Envelope, designed to reduce surgical site infections associated with cardiac implantable electronic devices (CIEDs). Its AIGISRx products contain the antimicrobial agents, rifampin and minocycline, which have been shown to reduce infection by pathogens responsible for the majority of CIED infections, including superbugs such as methicillin-resistant S. aureus (MRSA). The company was founded in 1998 by Satish Pulapura and Arikha Moses and is headquartered in Monmouth Junction, NJ. | Conseiller Juridique Général | - | - |
Formation de Mark Citron
University of Massachusetts | Undergraduate Degree |
Wagner College (New York) | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
General Counsel | 2 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Electronic Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
BioMimetic Therapeutics, Inc.
![]() BioMimetic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioMimetic Therapeutics, Inc. developed and sells protein therapeutics for tissue and organ regeneration. The company was founded by Samuel E. Lynch and David M. Renzi on April 14, 1999 and was headquartered in Franklin, TN. | Health Technology |
TYRX, Inc.
![]() TYRX, Inc. Electronic Equipment/InstrumentsElectronic Technology TYRX, Inc. designs and manufactures medical-pharmaceutical combination devices. The firm commercializes implantable combination drug and device products focused on infection control including the AIGISRx Antibacterial Envelope, designed to reduce surgical site infections associated with cardiac implantable electronic devices (CIEDs). Its AIGISRx products contain the antimicrobial agents, rifampin and minocycline, which have been shown to reduce infection by pathogens responsible for the majority of CIED infections, including superbugs such as methicillin-resistant S. aureus (MRSA). The company was founded in 1998 by Satish Pulapura and Arikha Moses and is headquartered in Monmouth Junction, NJ. | Electronic Technology |
- Bourse
- Insiders
- Mark Citron
- Expérience